Reproductive depression

@article{Studd2012ReproductiveD,
  title={Reproductive depression},
  author={John W. W. Studd and Rossella Elena Nappi},
  journal={Gynecological Endocrinology},
  year={2012},
  volume={28},
  pages={42 - 45}
}
  • J. Studd, R. Nappi
  • Published 1 March 2012
  • Psychology, Medicine
  • Gynecological Endocrinology
Reproductive depression is the depression in women that is related to the hormonal changes of the menstrual cycle, pregnancy and the menopause and is manifested clinically as premenstrual depression, postnatal depression and climacteric depression. These three components occur in the same vulnerable women in that a woman with depression in the menopausal transition will usually have a history of premenstrual syndrome (PMS; premenstrual dysphoric disorder [PMDD]), would have been in a good mood… 
Personal view: hormones and depression in women
  • J. Studd
  • Psychology, Medicine
    Climacteric : the journal of the International Menopause Society
  • 2015
TLDR
The hormonal causation of certain common types of depression in women and the successful treatment by estrogens should be understood by psychiatrists and gynecologists.
Reproductive Depression and the Response to Hormone Therapy
TLDR
The range and aetiology of depression in women is different than in men and cannot be understood without knowledge of the effect that oestrogen, progesterone and androgens have upon mood.
Assessment of perimenopausal depression: A review.
Premenstrual Syndrome and Premenstrual Dysphoric Disorder as Centrally Based Disorders
TLDR
PMS and PMDD encompass a variety of symptoms that occur during the luteal phase of the menstrual cycle and impair daily life activities and relationships, and pharmacological management aims to stabilize hormonal fluctuations and to restore the neuroendocrine balance.
Inflammatory markers in women with postpartum depressive symptoms
TLDR
The results indicate that women with PPD have elevated levels of some inflammatory biomarkers, and it is plausible that PPD is associated with a compromised adaptability of the immune system.
Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome
TLDR
New insights point to a role for genetic and epigenetic modifications of hormonal and neurotransmitter pathways, and inflammation is the potential link between peripheral and neurological integrated responses to stressors, which could lead both to develop targeted anti-inflammatory therapies and to define prevention strategies for the associated chronic inflammatory risk in PMS/PMDD.
Treatment of premenstrual disorders by suppression of ovulation by transdermal estrogens
  • J. Studd
  • Medicine, Biology
    Menopause international
  • 2012
The understanding of the cause and treatment of premenstrual disorders is confused but it is essentially the result of cyclical ovarian activity, usually ovulation, and an effective treatment should
Serotonin and Female Psychopathology
TLDR
In reviewing this female-specific topic, it is hoped to raise awareness to sex/gender differences in psychopathology, help identify at-risk populations and consider development of new treatment options.
Affective temperaments in pregnancy
TLDR
The third trimester of pregnancy is associated with significantly lower affective temperament, and younger age and lower levels of education were predictors of higher cyclothymic, anxious and depressive temperament scores.
...
...

References

SHOWING 1-10 OF 52 REFERENCES
Depression and the menopause: why antidepressants are not enough?
TLDR
The combination of the antidepressant with HT seems to offer the best therapeutic potential in terms of efficacy, rapidity of improvement and consistency of remission in the follow-up, as well as the synergistic effect between HT and antidepressants in treating menopausal depression.
Effects of gonadal steroids in women with a history of postpartum depression.
TLDR
The data provide direct evidence in support of the involvement of the reproductive hormones estrogen and progesterone in the development of postpartum depression in a subgroup of women and suggest that women with a history of post partum depression are differentially sensitive to mood-destabilizing effects of gonadal steroids.
Tailoring Treatment of Depression for Women Across the Reproductive Lifecycle: The Importance of Pregnancy, Vasomotor Symptoms, and Other Estrogen-Related Events in Psychopharmacology
TLDR
To attain optimal outcomes, modern psychopharmacologists must tailor treatment of depression to a woman's reproductive stage of life.
A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project.
TLDR
In the post-menopause, FSH levels are markedly raised, E2 levels are low, whereas inhibin B and AMH are undetectable, a time of marked hormonal instability.
Ovarian cycle syndrome
  • J. Studd
  • Psychology, Medicine
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2009
TLDR
It is logical that the diagnosis of ovarian cycle syndrome should be used to include all of the cyclical physical, behavioural and emotional changes of mood that occur monthly following ovulation and that this name should replace PMS or PMDD.
Oestrogens and progestins for preventing and treating postpartum depression.
TLDR
Oestrogen therapy was associated with a greater improvement in depression scores than placebo among women with severe depression, and synthetic progestogens should be used with significant caution in the postpartum period.
Hormones and depression in women
  • J. Studd, N. Panay
  • Psychology
    Climacteric : the journal of the International Menopause Society
  • 2004
TLDR
This critical review guides the reader through the plethora of data, from the earliest reports of menstrual madness in the nineteenth century to neurobiological work in the new millennium, that illustrates that although the effect of estrogen on the central nervous system, particularly on mood and depression, remains a controversial area, there is now considerable evidence for the psychotherapeutic benefits of estrogens in the triad of hormone-responsive depressive disorders.
Transdermal oestrogen for treatment of severe postnatal depression
Why are estrogens rarely used for the treatment of depression in women?
  • J. Studd
  • Psychology, Medicine
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2007
The short answer to this question could be that they do not work, but that is not true. It is much more likely that a turf war is developing between psychiatrists and gynaecologists/endocrinologists
Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.
TLDR
Transdermal estradiol replacement is an effective treatment of depression for perimenopausal women and sustained antidepressant benefit of treatment after the 4-week washout period, although somatic complaints increased in frequency and intensity.
...
...